{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T01:51:00Z","timestamp":1755222660726,"version":"3.43.0"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p>Cerebral X-linked adrenoleukodystrophy (cALD) is an X-linked peroxisomal disorder caused by pathogenic variation in the <jats:italic>ABCD1<\/jats:italic> gene, characterized by progressive central nervous system demyelination leading to severe neurocognitive decline, as well as concomitant adrenal insufficiency resulting from fatty acid accumulation. When instituted early, haematopoietic stem cell transplantation (HSCT) can halt neurological disease progression. Whole genome sequencing can clarify the diagnosis of cALD but may also reveal conditions with significant clinical implications, as in our case. To our knowledge, this is the first published case where an incidental finding of cystic fibrosis influenced pre-HSCT workup and subsequent management in a child with cALD. A 6-year-old boy presented with subacute neuroregression, manifesting as deteriorating cognition and speech, hyperactivity, clumsiness, and swallowing dysfunction. Brain MRI confirmed symmetrical demyelinating lesions consistent with cALD, and whole genome sequencing (WGS) identified a maternally-inherited pathogenic <jats:italic>ABCD1<\/jats:italic>(NM_000033.4):c.521A&amp;gt;G (p.Tyr174Cys) variant. WGS also incidentally identified compound heterozygosity for two pathogenic variants in <jats:italic>CFTR<\/jats:italic>, supporting an incidental cystic fibrosis (CF) diagnosis, clinically verified by an abnormal sweat test and radiological findings of subclinical bronchiectasis, as the child was asymptomatic. This influenced the HSCT conditioning regimen prescription and reinforced the need for enhanced infectious prophylaxis and vigilant respiratory support. This case highlights the potential of comprehensive genomic approaches to reveal previously undetected comorbidities. Integrating CF management into a cALD-directed HSCT protocol mitigated peri-transplant risks, demonstrating the value of multidisciplinary care when incidental diagnoses emerge.<\/jats:p>","DOI":"10.3389\/fped.2025.1650645","type":"journal-article","created":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T04:10:58Z","timestamp":1754885458000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: Incidental diagnosis of cystic fibrosis via whole genome sequencing alters HSCT planning in a child with cerebral X-linked adrenoleukodystrophy"],"prefix":"10.3389","volume":"13","author":[{"given":"Jann Adriel Chua","family":"Sy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Poh Lin","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremy Bingyuan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stacey Kiat-Hong","family":"Tay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-Lin","family":"Chin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,8,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1038\/361726a0","article-title":"Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters","volume":"361","author":"Mosser","year":"1993","journal-title":"Nature"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1750-1172-7-51","article-title":"X-linked adrenoleukodystrophy (X-ALD): clinical presentation and guidelines for diagnosis, follow-up and management","volume":"7","author":"Engelen","year":"2012","journal-title":"Orphanet J Rare Dis"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1182\/blood-2011-01-329235","article-title":"Outcomes after allogeneic hematopoietic cell transplantation for childhood cerebral adrenoleukodystrophy: the largest single-institution cohort report","volume":"118","author":"Miller","year":"2011","journal-title":"Blood"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1080\/14712598.2022.2124857","article-title":"Treatment of cerebral adrenoleukodystrophy: allogeneic transplantation and lentiviral gene therapy","volume":"22","author":"Gupta","year":"2022","journal-title":"Expert Opin Biol Ther"},{"key":"B5","doi-asserted-by":"publisher","first-page":"100866","DOI":"10.1016\/j.gim.2023.100866","article-title":"ACMG SF v3.2 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG)","volume":"25","author":"Miller","year":"2023","journal-title":"Genet Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"e154","DOI":"10.3928\/19382359-20190327-01","article-title":"Review of cystic fibrosis","volume":"48","author":"Goetz","year":"2019","journal-title":"Pediatr Ann"},{"key":"B7","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1182\/blood-2017-09-806489","article-title":"A landscape of germ line mutations in a cohort of inherited bone marrow failure patients","volume":"131","author":"Bluteau","year":"2018","journal-title":"Blood"},{"key":"B8","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1002\/humu.1227","article-title":"ABCD1 mutations and the X-linked adrenoleukodystrophy mutation database: role in diagnosis and clinical correlations","volume":"18","author":"Kemp","year":"2001","journal-title":"Hum Mutat"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1111\/j.1471-4159.2007.04457.x","article-title":"Adrenoleukodystrophy: subcellular localization and degradation of adrenoleukodystrophy protein (ALDP\/ABCD1) with naturally occurring missense mutations","volume":"101","author":"Takahashi","year":"2007","journal-title":"J Neurochem"},{"key":"B10","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1186\/s12944-024-02361-0","article-title":"From gene to therapy: a review of deciphering the role of ABCD1 in combating X-linked adrenoleukodystrophy","volume":"23","author":"Zuo","year":"2024","journal-title":"Lipids Health Dis"},{"key":"B11","article-title":"ClinVar","year":""},{"key":"B12","article-title":"ClinVar","year":""},{"key":"B13","doi-asserted-by":"publisher","first-page":"S475","DOI":"10.1590\/S0102-311X2008001600002","article-title":"Cystic fibrosis and neonatal screening","volume":"24","author":"Rodrigues","year":"2008","journal-title":"Cad Saude Publica"},{"key":"B14","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1159\/000029497","article-title":"Genotype and phenotype in cystic fibrosis","volume":"67","author":"Zielenski","year":"2000","journal-title":"Respiration"},{"key":"B15","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.jcf.2014.11.001","article-title":"The p.Gly622Asp (G622D) mutation, frequently found in Reunion Island and in black populations, is associated with a wide spectrum of CF and CFTR-RD phenotypes","volume":"14","author":"Marion","year":"2015","journal-title":"J Cyst Fibros"},{"key":"B16","article-title":"The Clinical and Functional Translation of CFTR (CFTR2)","year":""},{"key":"B17","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1016\/j.jpeds.2016.09.064","article-title":"Diagnosis of cystic fibrosis: consensus guidelines from the cystic fibrosis foundation","volume":"181","author":"Farrell","year":"2017","journal-title":"J Pediatr"},{"key":"B18","first-page":"1761","article-title":"Adrenoleukodystrophy: a scoring method for brain MR observations","volume":"15","author":"Loes","year":"1994","journal-title":"Am J Neuroradiol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fped.2019.00433","article-title":"Hematopoietic stem cell transplantation in inborn errors of metabolism","volume":"7","author":"Tan","year":"2019","journal-title":"Front Pediatr"},{"key":"B20","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/bmt.2015.277","article-title":"Long-term outcomes of fludarabine, melphalan and antithymocyte globulin as reduced-intensity conditioning regimen for allogeneic hematopoietic stem cell transplantation in children with primary immunodeficiency disorders: a prospective single center study","volume":"51","author":"Hamidieh","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"B21","doi-asserted-by":"publisher","first-page":"883826","DOI":"10.3389\/fimmu.2022.883826","article-title":"Diagnostic value of a protocolized in-depth evaluation of pediatric bone marrow failure: a multi-center prospective cohort study","volume":"13","author":"Atmar","year":"2022","journal-title":"Front Immunol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/j.bbmt.2016.01.026","article-title":"A reduced-intensity conditioning regimen for patients with dyskeratosis congenita undergoing hematopoietic stem cell transplantation","volume":"22","author":"Nelson","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"B23","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1089\/ped.2019.0990","article-title":"Busulfan-Induced lung injury in pediatric oncology patients\u2014review of the literature with an illustrative case","volume":"32","author":"Matijasic","year":"2019","journal-title":"Pediatr Allergy Immunol Pulmonol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1002\/acn3.526","article-title":"Post-transplant adaptive function in childhood cerebral adrenoleukodystrophy","volume":"5","author":"Pierpont","year":"2018","journal-title":"Ann Clin Transl Neurol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1177\/03008916241301912","article-title":"Combined CAR-T\/HSCT approach in a patient with refractory acute lymphoblastic leukemia and cystic fibrosis","author":"Di Majo","year":"2024","journal-title":"Tumori J"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1183\/09031936.00052806","article-title":"Bronchiolitis obliterans following haematopoietic stem cell transplantation","volume":"29","author":"Soubani","year":"2007","journal-title":"Eur Respir J"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1378\/chest.12-1708","article-title":"An update on pulmonary complications of hematopoietic stem cell transplantation","volume":"144","author":"Chi","year":"2013","journal-title":"Chest"},{"key":"B28","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1002\/cncr.24897","article-title":"Pulmonary dysfunction in survivors of childhood hematologic malignancies after allogeneic hematopoietic stem cell transplantation","volume":"116","author":"Inaba","year":"2010","journal-title":"Cancer"},{"key":"B29","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41409-022-01828-x","article-title":"Clinically relevant germline variants in allogeneic hematopoietic stem cell transplant recipients","volume":"58","author":"Lahtinen","year":"2023","journal-title":"Bone Marrow Transplant"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2025.1650645\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T04:11:00Z","timestamp":1754885460000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2025.1650645\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,11]]},"references-count":29,"alternative-id":["10.3389\/fped.2025.1650645"],"URL":"https:\/\/doi.org\/10.3389\/fped.2025.1650645","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,11]]},"article-number":"1650645"}}